Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

Overview

Journal Neuropsychiatr Dis Treat

Publisher Dove Medical Press

Specialty Psychiatry

Date 2020 May 6

PMID 32368066

Citations 24

Authors

Murad Atmaca

Affiliations

Soon will be listed here.

Abstract

Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed.

Citing Articles

Ameliorative Effect of Rauwolfia vomitoria Ethanol Extract on the Erectile Dysfunction Complicated with Coronary Artery Disease: An In-Vivo and Molecular Docking Approach.

Muritala H, Abdulrahman R, Oyewusi H, Muhammad H Cell Biochem Biophys. 2025; .

PMID: 40080352 DOI: 10.1007/s12013-025-01713-6.

Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials.

de Aquino A, Sarmento A, Teixeira R, Batista T, de Freitas C, Marmol J Clinics (Sao Paulo). 2025; 80:100602.

PMID: 39985829 PMC: 11904590. DOI: 10.1016/j.clinsp.2025.100602.

Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study.

Christensen M, Canellas F, Loft H, Montejo A Neuropsychiatr Dis Treat. 2024; 20:1475-1489.

PMID: 39100571 PMC: 11297586. DOI: 10.2147/NDT.S473056.

Scopoletin mitigates maternal separation-induced anxiety-like and depression-like behaviors in male mice through modulation of the Sirt1/NF-κB pathway.

Alqudah A, Qnais E, Gammoh O, Bseiso Y, Wedyan M, Alqudah M Psychopharmacology (Berl). 2024; 241(11):2347-2362.

PMID: 38886190 DOI: 10.1007/s00213-024-06639-0.

Sialic Acid-Functionalized Gold Nanoparticles for Sensitive and Selective Colorimetric Determination of Serotonin.

Avci B, Akpinar Y, Ertas G, Volkan M ACS Omega. 2024; 9(22):23832-23842.

PMID: 38854544 PMC: 11154895. DOI: 10.1021/acsomega.4c01859.

References

Higgins A, Barker P, Begley C . 'Veiling sexualities': a grounded theory of mental health nurses responses to issues of sexuality. J Adv Nurs. 2008; 62(3):307-17. DOI: 10.1111/j.1365-2648.2007.04586.x. View

Clayton A, Pradko J, Croft H, Montano C, Leadbetter R, Bass K . Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002; 63(4):357-66. DOI: 10.4088/jcp.v63n0414. View

Ekselius L, von Knorring L . Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol. 2001; 21(2):154-60. DOI: 10.1097/00004714-200104000-00006. View

Behnia B, Heinrichs M, Bergmann W, Jung S, Germann J, Schedlowski M . Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Horm Behav. 2014; 65(3):308-18. DOI: 10.1016/j.yhbeh.2014.01.009. View

Dewan M, Anand V . Evaluating the tolerability of the newer antidepressants. J Nerv Ment Dis. 1999; 187(2):96-101. DOI: 10.1097/00005053-199902000-00005. View

Bet P, Hugtenburg J, Penninx B, Hoogendijk W . Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol. 2013; 23(11):1443-51. DOI: 10.1016/j.euroneuro.2013.05.001. View

Michelson D, Kociban K, Tamura R, Morrison M . Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res. 2002; 36(3):147-52. DOI: 10.1016/s0022-3956(01)00060-7. View

Salehi I, Hosseini S, Haghighi M, Jahangard L, Bajoghli H, Gerber M . Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder. J Psychiatr Res. 2016; 76:1-8. DOI: 10.1016/j.jpsychires.2016.01.012. View

Gartlehner G, Hansen R, Morgan L, Thaler K, Lux L, Van Noord M . Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 2011; 155(11):772-85. DOI: 10.7326/0003-4819-155-11-201112060-00009. View

10.

Pedersen C, Boccia M . Oxytocin maintains as well as initiates female sexual behavior: effects of a highly selective oxytocin antagonist. Horm Behav. 2002; 41(2):170-7. DOI: 10.1006/hbeh.2001.1736. View

11.

PATTERSON W . Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1993; 54(2):71. View

12.

Kang B, Lee S, Kim M, Cho M . A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol. 2002; 17(6):279-84. DOI: 10.1002/hup.409. View

13.

Hengartner M, Ploderl M . Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!. Front Psychiatry. 2018; 9:517. PMC: 6199395. DOI: 10.3389/fpsyt.2018.00517. View

14.

Modell J, Katholi C, Modell J, DePalma R . Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther. 1997; 61(4):476-87. DOI: 10.1016/S0009-9236(97)90198-3. View

15.

Watson J, Davies T . ABC of mental health. Psychosexual problems. BMJ. 1997; 315(7102):239-42. PMC: 2127153. DOI: 10.1136/bmj.315.7102.239. View

16.

Ekselius L, von Knorring L, Eberhard G . A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharmacol. 1998; 12(6):323-31. DOI: 10.1097/00004850-199711000-00005. View

17.

Mazer N, Leiblum S, Rosen R . The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause. 2000; 7(5):350-63. DOI: 10.1097/00042192-200007050-00009. View

18.

Kennedy S, Dickens S, Eisfeld B, Bagby R . Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord. 2000; 56(2-3):201-8. DOI: 10.1016/s0165-0327(99)00050-6. View

19.

Keltner N, McAfee K, Taylor C . Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care. 2002; 38(3):111-6. View

20.

Preskorn S . Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 1995; 56 Suppl 6:12-21. View